Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus tourniquet versus tourniquet alone during abdominal myomectomy
PACTR202312679640849Completed
- Sponsor
- DR. AMULU IFEANYI VICTOR
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Fibromyoma (LM) comparing Tranexamic acid and tourniquet group with Tourniquet and placebo alone group (2 arms). Primary endpoint: Mean estimated intraoperative blood loss. Started Jan 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202312679640849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312679640849.